| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparative study of the use of the Herpchek™ assay vs viral culture for the detection of labial herpes simplex virus (HSV) in a clinical drug trial
|
|
|
1997
|
34 |
2 |
p. A72-
1 p.
|
artikel
|
| 2 |
Activity of benzimidazole riboside 1263W94 (5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole) against Epstein-Barr virus
|
Zacny, V.L.
|
|
1997
|
34 |
2 |
p. A85-
1 p.
|
artikel
|
| 3 |
Altered expression of inhibitory cytokines, interleukin-4 (IL-4) and transforming growth factor-beta1 (TGFβ1) in bone marrow stromal cells induced by the ecotropic murine leukemia virus (MuLV)
|
Oakley, Oliver R.
|
|
1997
|
34 |
2 |
p. A60-
1 p.
|
artikel
|
| 4 |
A new antisense contruct for the genetic treatment of antigen-specific human lymphocytes an approach to adoptive immunotherapy of aids
|
Palu, G
|
|
1997
|
34 |
2 |
p. A43-
1 p.
|
artikel
|
| 5 |
A new class of carbocyclic influenza neuraminidase inhibitors: Structure-activity relationships
|
|
|
1997
|
34 |
2 |
p. A86-
1 p.
|
artikel
|
| 6 |
Aniti-influenza virus activity by circular dumbbell RNA/DNA chimeric oligo-nucleotides
|
Yamakawa, H.
|
|
1997
|
34 |
2 |
p. A87-
1 p.
|
artikel
|
| 7 |
A non-human primate model for in vivo evaluation of anti-HIV-1 drugs
|
|
|
1997
|
34 |
2 |
p. A49-
1 p.
|
artikel
|
| 8 |
A novel anti-rhinoviral compound directed at 3C protease can diminish IL-6 and IL-8 production in a transformed bronchial epithelial cell line
|
Zalman, L.S.
|
|
1997
|
34 |
2 |
p. A89-
1 p.
|
artikel
|
| 9 |
Anti-CD3/2-chloro-5-nitrobenzoic acid costimulation differentially enhances T-cell growth without inducing HIV-1 replication
|
|
|
1997
|
34 |
2 |
p. A59-
1 p.
|
artikel
|
| 10 |
Anti-herpes activities of 2-thio-pyrimidine analogues
|
|
|
1997
|
34 |
2 |
p. A47-
1 p.
|
artikel
|
| 11 |
Anti-HIV activity and metabolism of phosphoramidate derivatives of D4T-MP with variations in the amino acid moiety
|
Naesens, L.
|
|
1997
|
34 |
2 |
p. A54-
1 p.
|
artikel
|
| 12 |
Anti-HSV-1 activity of phenolic polymers derived from p-diphenolic starting compounds
|
Klöcking, R.
|
|
1997
|
34 |
2 |
p. A77-
1 p.
|
artikel
|
| 13 |
Anti-respiratory syncytial virus activity of dendrimer polyanions
|
|
|
1997
|
34 |
2 |
p. A88-
1 p.
|
artikel
|
| 14 |
Anti-respiratory syncytial virus (RSV) activity of 2–5a antisense oligonucleotide chimeras
|
|
|
1997
|
34 |
2 |
p. A89-
1 p.
|
artikel
|
| 15 |
Antiretroviral activity and metabolism of bis(POC)PMPA, an oral bioavailable prodrug of PMPA
|
|
|
1997
|
34 |
2 |
p. A49-
1 p.
|
artikel
|
| 16 |
Anti-retrovirus activity and pharmacokinetics in mice of bis(POC)-PMPA, the bis(isopropyloxycarbonyloxymethyl) oral prodrug of PMPA
|
Naesens, L.
|
|
1997
|
34 |
2 |
p. A50-
1 p.
|
artikel
|
| 17 |
Antirhinoviral vinyl acetylene benzimidazoles
|
Tebbe, M.J.
|
|
1997
|
34 |
2 |
p. A75-
1 p.
|
artikel
|
| 18 |
Antiviral activity, and biological properties of vinylacetylene analogs of enviroxime
|
Spitzer, W.A.
|
|
1997
|
34 |
2 |
p. A87-
1 p.
|
artikel
|
| 19 |
Antiviral activity of a novel compound P-4018 against different strains of herpes simplex virus in vitro and in vivo
|
Andrei, G.
|
|
1997
|
34 |
2 |
p. A76-
1 p.
|
artikel
|
| 20 |
Antiviral activity of C-2 analogs of enviroxime. An exploration of the role of critical functionality
|
Spitzer, W.A.
|
|
1997
|
34 |
2 |
p. A87-
1 p.
|
artikel
|
| 21 |
Antiviral activity of famciclovir therapy on HBV replication in patients with chronic hepatitis B
|
Zoulim, F.
|
|
1997
|
34 |
2 |
p. A53-
1 p.
|
artikel
|
| 22 |
Arabinogalactan (9kDa)-araAMP, a novel liver-targeting conjugate inhibits selectively HBV replication in vitro
|
|
|
1997
|
34 |
2 |
p. A64-
1 p.
|
artikel
|
| 23 |
A single sequence change destabilizes the influenza virus neuraminidase tetramer
|
|
|
1997
|
34 |
2 |
p. A73-
1 p.
|
artikel
|
| 24 |
AZT treatment of HIV-1-infected macrophages prevents apoptosis and necrosis in human astrocytic cells
|
Perno, CF.
|
|
1997
|
34 |
2 |
p. A49-
1 p.
|
artikel
|
| 25 |
Betain-type fluoroalkylated oligomers are potent inhibitors of human immunodeficiency viruses type 1 (HIV-1) and other enveloped viruses
|
Fujiwara, M.
|
|
1997
|
34 |
2 |
p. A56-
1 p.
|
artikel
|
| 26 |
BMS-200,475, a new anti-hepatitis B compound; Metabolic studies and comparison with 3TC, penciclovir, and lobucavir
|
|
|
1997
|
34 |
2 |
p. A64-
1 p.
|
artikel
|
| 27 |
BMS-200475, a novel carbocyclic 2′-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro
|
|
|
1997
|
34 |
2 |
p. A64-
1 p.
|
artikel
|
| 28 |
Capture of HIV-1 gp120 and virions by lectin-immobilized polystyrene nanospheres: Potential approach toward prevention of HIV-1 infection
|
Hayakawa, T.
|
|
1997
|
34 |
2 |
p. A62-
1 p.
|
artikel
|
| 29 |
Carbocyclic guanosine nucleoside BMS-200475 treatment inhibits woodchuck hepatitis virus (WHV) viremia in WHV-carriers
|
|
|
1997
|
34 |
2 |
p. A65-
1 p.
|
artikel
|
| 30 |
Characterization of a novel fusion inhibitor of influenza A virus
|
|
|
1997
|
34 |
2 |
p. A93-
1 p.
|
artikel
|
| 31 |
Characterization of influenza A viruses that are resistant to a fusion inhibitor related to podocarpic acid
|
|
|
1997
|
34 |
2 |
p. A86-
1 p.
|
artikel
|
| 32 |
Characterization of recombinant hepatitis C virus NS5B gene product (RDRP)
|
Hagedorn, CH
|
|
1997
|
34 |
2 |
p. A93-
1 p.
|
artikel
|
| 33 |
Cidofovir: Induction of apoptosis in human papilloma virus (HPV)-containing cell lines
|
Andrei, G.
|
|
1997
|
34 |
2 |
p. A72-
1 p.
|
artikel
|
| 34 |
Combination of antiviral with anti-inflammatory preparations for the topical treatment for recurrent herpes simplex assessed using a zosteriform murine infection model
|
Awan, Aftab. R.
|
|
1997
|
34 |
2 |
p. A70-
1 p.
|
artikel
|
| 35 |
Comparative activation of 2′-deoxycytidine and antiviral oxathiolane cytosine nucleosides by different mammalian liver extracts
|
|
|
1997
|
34 |
2 |
p. A65-
1 p.
|
artikel
|
| 36 |
Comparative metabolism of the antiviral dimer AZT-P-ddl and the monomers zidovudine and didanosine by rat, monkey and human hepatocytes
|
Pan-Zhou, Xin-Ru
|
|
1997
|
34 |
2 |
p. A61-
1 p.
|
artikel
|
| 37 |
Comparison of the viral pharmacodynamics of 3TC in chronically infected woodchucks and humans
|
|
|
1997
|
34 |
2 |
p. A53-
1 p.
|
artikel
|
| 38 |
Coupled in vitro transcription/translation as a tool for the study of human cytomegalovirus DNA polymerase
|
|
|
1997
|
34 |
2 |
p. A83-
1 p.
|
artikel
|
| 39 |
Cyclic HPMPC is safe and highly effective against guinea pig cytomegalovirus infection in immunocompromised animals
|
|
|
1997
|
34 |
2 |
p. A85-
1 p.
|
artikel
|
| 40 |
Decreased thymidine kinase-1 activity in vitro and in ex vivo stimulated PBMC's of HIV-1 patients treated with different antiretroviral agents
|
Gröschel, B.
|
|
1997
|
34 |
2 |
p. A59-
1 p.
|
artikel
|
| 41 |
Design and biochemical properties of orally active inhibitors of herpes simplex virus thymidine kinase
|
Martin, JA
|
|
1997
|
34 |
2 |
p. A47-
1 p.
|
artikel
|
| 42 |
Design of novel, conformationally restricted HIV protease inhibitors
|
Tung, R.D.
|
|
1997
|
34 |
2 |
p. A43-
1 p.
|
artikel
|
| 43 |
Development of a hepatitis C virus RNA helicase high throughput assay
|
Risano, C.
|
|
1997
|
34 |
2 |
p. A68-
1 p.
|
artikel
|
| 44 |
Development of an Elisa assay for determining antiviral activity against Epstein-Barr virus replication
|
|
|
1997
|
34 |
2 |
p. A85-
1 p.
|
artikel
|
| 45 |
Development of resistance to anti-HIV drugs in primary macrophages
|
Perno, CF.
|
|
1997
|
34 |
2 |
p. A59-
1 p.
|
artikel
|
| 46 |
Differential antiviral activity of several IMP dehydrogenase inhibitors
|
Neyts, J.
|
|
1997
|
34 |
2 |
p. A87-
1 p.
|
artikel
|
| 47 |
Discovery of antiviral agents for hepatitis C: Development of a high throughput assay for the NS3 nucleoside triphosphatase
|
|
|
1997
|
34 |
2 |
p. A68-
1 p.
|
artikel
|
| 48 |
Discovery of peptide and small molecule inhibitors of paramyxovirus fusion
|
|
|
1997
|
34 |
2 |
p. A75-
1 p.
|
artikel
|
| 49 |
Disulfide-containing macrolides that inhibit a late stage of the replicative cycle of human immunodeficiency virus
|
Witvrouw, M.
|
|
1997
|
34 |
2 |
p. A48-
1 p.
|
artikel
|
| 50 |
Dose- and treatment duration-dependence of ganciclovir against murine cytomegalovirus infection in severe combined immunodeficient mice—experimental and clinical implications
|
Duan, J.
|
|
1997
|
34 |
2 |
p. A84-
1 p.
|
artikel
|
| 51 |
Drug delivery via amino acid phosphoramidates
|
Wagner, Carston R.
|
|
1997
|
34 |
2 |
p. A61-
1 p.
|
artikel
|
| 52 |
Dual therapy with IL-12 and IFNα provides a novel approach to the management of chronic viral disease
|
Carr, JA
|
|
1997
|
34 |
2 |
p. A65-
1 p.
|
artikel
|
| 53 |
(E)-2′-deoxy-(fluoromethylene) cytidine potently inhibits replication of human cytomegalovirus strains both sensitive and resistant to ganciclovir and/or foscarnet and potentiates antiviral effects of ganciclovir
|
Cinatl Jr., J.
|
|
1997
|
34 |
2 |
p. A46-
1 p.
|
artikel
|
| 54 |
Effectiveness of combination therapies with 3TC, famciclovir, and alpha interferon against woodchuck hepatitis virus replication in chronically-infected woodchucks: Model for potential anti-HBV treatments
|
|
|
1997
|
34 |
2 |
p. A52-
1 p.
|
artikel
|
| 55 |
Effect of cidofovir on the tumor growth of SiHa (human cervical carcinoma) cells in nude mice
|
Snoeck, R.
|
|
1997
|
34 |
2 |
p. A69-
1 p.
|
artikel
|
| 56 |
Effect of β-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HEPG2 cells
|
|
|
1997
|
34 |
2 |
p. A52-
1 p.
|
artikel
|
| 57 |
Effect of indomethacin (INDO) on antiviral and immune response of peripheral blood mononuclear cells (PBMC8) from patients with chronic hepatitis B virus (HBV) infection
|
Andreone, P
|
|
1997
|
34 |
2 |
p. A67-
1 p.
|
artikel
|
| 58 |
Effect of neutralizing antibody and interferon on antibody resistant mutants of poliovirus
|
|
|
1997
|
34 |
2 |
p. A89-
1 p.
|
artikel
|
| 59 |
Effect of prophylactic and therapeutic administration of topical 9-[2-(phosphonomethoxy)ethyl]guanine (PMEG) in genital herpes simplex virus (HSV) infections of guinea pigs
|
|
|
1997
|
34 |
2 |
p. A81-
1 p.
|
artikel
|
| 60 |
Effects of β-D-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine 5′-triphosphate (β-D-D4FC-TP) and its β-L-enantiomer 5′-triphosphate (β-L-D4FC-TP) on viral DNA polymerases
|
|
|
1997
|
34 |
2 |
p. A66-
1 p.
|
artikel
|
| 61 |
Effects of Viramid in treatment of influenza
|
Kubar, O.
|
|
1997
|
34 |
2 |
p. A88-
1 p.
|
artikel
|
| 62 |
Efficacy of GS 4104 in ferrets infected with influenza A virus
|
Kim, C.U.
|
|
1997
|
34 |
2 |
p. A74-
1 p.
|
artikel
|
| 63 |
Efficacy of the neuraminidase inhibitor GG167 in the treatment of influenza virus infections
|
|
|
1997
|
34 |
2 |
p. A74-
1 p.
|
artikel
|
| 64 |
Efficacy, pharmacokinetics and in vivo anti-HIV activity of UC781
|
|
|
1997
|
34 |
2 |
p. A62-
1 p.
|
artikel
|
| 65 |
Enhanced penetration of acyclovir into brain tissue by RMP-7 in a rat model of herpes encephalitis
|
|
|
1997
|
34 |
2 |
p. A70-
1 p.
|
artikel
|
| 66 |
Enhancement of the ion-pairing HPLC analysis of cellular 2′-deoxyadenosine 5′-triphosphate, 2′,3′-dideoxyadenosine 5′-triphosphate and 2′-fluoro-2′,3′-dideoxyadenosine 5′-triphosphate pools through periodate-treatment and fluorogenic derivatization
|
Zhang, H.
|
|
1997
|
34 |
2 |
p. A49-
1 p.
|
artikel
|
| 67 |
Evaluation of a live attenuated recombinant virus RAV 9395 as an HSV-2 vaccine in guinea pigs
|
Spector, F.C.
|
|
1997
|
34 |
2 |
p. A71-
1 p.
|
artikel
|
| 68 |
Evaluation of liposome-encapsulated foscarnet in the rabbit eye
|
Hoffmann, F.
|
|
1997
|
34 |
2 |
p. A82-
1 p.
|
artikel
|
| 69 |
Evaluation of potential treatments for Epstein-Barr virus infections in man using a murine gammaherpesvirus-68 infection model
|
|
|
1997
|
34 |
2 |
p. A71-
1 p.
|
artikel
|
| 70 |
Evaluation of the antiviral activity and cytotoxicity of nelfinavir in combination with reverse transcriptase and protease inhibitors in an in vitro acute HIV-1 infection model
|
Bloom, L.A.
|
|
1997
|
34 |
2 |
p. A58-
1 p.
|
artikel
|
| 71 |
Evaluation of the antiviral activity and cytotoxicity of peptidic inhibitors of human rhinovirus 3C protease, a novel target for antiviral intervention
|
Patick, A.K.
|
|
1997
|
34 |
2 |
p. A75-
1 p.
|
artikel
|
| 72 |
Evaluation of the antiviral activity of an organomatallic compound in the guinea pig model of genital herpes
|
|
|
1997
|
34 |
2 |
p. A81-
1 p.
|
artikel
|
| 73 |
Evaluation of the antiviral nucleoside, lobucavir, in chronically woodchuck hepatitis virus (WHV) infected woodchucks
|
|
|
1997
|
34 |
2 |
p. A65-
1 p.
|
artikel
|
| 74 |
Foscarnet inhibits differentiation of osteoblasts in vitro
|
|
|
1997
|
34 |
2 |
p. A80-
1 p.
|
artikel
|
| 75 |
From carbovir to 1592
|
Vince, Robert
|
|
1997
|
34 |
2 |
p. A42-
1 p.
|
artikel
|
| 76 |
Further investigation into the recurrence of infectious virus in the nervous system of mice infected with HSV-1 on cessation of valaciclovir therapy
|
Thackray, A.M.
|
|
1997
|
34 |
2 |
p. A81-
1 p.
|
artikel
|
| 77 |
Ganciclovir (GCV) resistance caused by oral GCV in an heart transplant recipient with multiple HCMV strains in blood
|
Baldanti, F.
|
|
1997
|
34 |
2 |
p. A84-
1 p.
|
artikel
|
| 78 |
Ganciclovir (GCV) resistance due to a new mutation in the UL97 gene product in a HCMV isolate from an AIDS patient
|
Baldanti, F.
|
|
1997
|
34 |
2 |
p. A84-
1 p.
|
artikel
|
| 79 |
Genotypic characterization of various herpes simplex virus type 1 (HSV-1) clones resistant to acyclic nucleoside phosphonates
|
Andrei, G.
|
|
1997
|
34 |
2 |
p. A79-
1 p.
|
artikel
|
| 80 |
GS 4104: A highly potent orally bioavailable influenza neuraminidase inhibitor
|
|
|
1997
|
34 |
2 |
p. A86-
1 p.
|
artikel
|
| 81 |
GS 4104 is a highly bioavailable prodrug of the novel, potent influenza neuraminidase inhibitor GS 4071
|
|
|
1997
|
34 |
2 |
p. A74-
1 p.
|
artikel
|
| 82 |
GS 4071 is a potent and selective inhibitor of the growth and neuraminidase activity of influenza A and B viruses in vitro
|
Mendel, D.B.
|
|
1997
|
34 |
2 |
p. A73-
1 p.
|
artikel
|
| 83 |
Hepatitis C virus infection in SCID mice using xenografted human livers
|
|
|
1997
|
34 |
2 |
p. A69-
1 p.
|
artikel
|
| 84 |
Herpes simplex virus in the mouse: zosteriform lesions with adoptive transfer of immune cells: a model which mimics human recurrent disease
|
Awan, Aftab. R.
|
|
1997
|
34 |
2 |
p. A81-
1 p.
|
artikel
|
| 85 |
Highly potent UC analogs with efficacy against NNRTI-resistant viruses
|
|
|
1997
|
34 |
2 |
p. A56-
1 p.
|
artikel
|
| 86 |
HIV-1 Tat protein potentiates zidovudine-induced bone marrow suppression
|
|
|
1997
|
34 |
2 |
p. A60-
1 p.
|
artikel
|
| 87 |
Human immunodeficiency virus gp120 as the primary target of action of AR177 (Zintevir)
|
Este, J.A.
|
|
1997
|
34 |
2 |
p. A57-
1 p.
|
artikel
|
| 88 |
2-Hydroxymethylcyclopropylidenemethylpurines and -pyrimidines - New nucleoside analogs with a broad spectrum antiviral activity
|
Zemlicka, J.
|
|
1997
|
34 |
2 |
p. A46-
1 p.
|
artikel
|
| 89 |
Identification and characterization of topical microbicides: Inhibitors of HIV sexual transmission
|
Halliday, S.
|
|
1997
|
34 |
2 |
p. A61-
1 p.
|
artikel
|
| 90 |
Identification of an antisense oligonucleotide with in vivo activity against human papillomavirus. 2. Efficacy against benign human genital condyloma in a mouse xenograft model
|
Lewis, E.J.
|
|
1997
|
34 |
2 |
p. A72-
1 p.
|
artikel
|
| 91 |
Identification of an antisense oligonucleotide with in vivo activity against human papillomavirus. 1. In vitro evaluation of oligonucleotides
|
|
|
1997
|
34 |
2 |
p. A71-
1 p.
|
artikel
|
| 92 |
Identification of BMS-200,475 as a novel and potent inhibitor of hepatitis B virus replication
|
|
|
1997
|
34 |
2 |
p. A51-
1 p.
|
artikel
|
| 93 |
Identification of the antiviral nucleoside drug binding site of HIV-1 integrase by proteolytic peptide mapping
|
|
|
1997
|
34 |
2 |
p. A42-
1 p.
|
artikel
|
| 94 |
IgM anti-preS2 monitoring during combined corticosteroid/interferon alpha2b therapy in chronic hepatitis B
|
|
|
1997
|
34 |
2 |
p. A66-
1 p.
|
artikel
|
| 95 |
Inactivation of enveloped and non-enveloped viruses by ozone induced oxidative stress
|
|
|
1997
|
34 |
2 |
p. A91-
1 p.
|
artikel
|
| 96 |
Incorporation of anti-HIV nucleotide analogs and nucleoside phosphonates into DNA by human DNA polymerases α, β and γ
|
Cihlar, T.
|
|
1997
|
34 |
2 |
p. A60-
1 p.
|
artikel
|
| 97 |
Individual pre-screening of antiviral substances using CYTOMORPH-b
|
Klöcking, R.
|
|
1997
|
34 |
2 |
p. A82-
1 p.
|
artikel
|
| 98 |
Induction of genetic damage and apoptosis by ganciclovir in Chinese hamster ovary cells transfected with the thymidine kinase (tk) gene of HSV-1
|
Thust, Rudolf
|
|
1997
|
34 |
2 |
p. A79-
1 p.
|
artikel
|
| 99 |
Influence of replacement of oxygen with sulfur at the 4′-position on the antiherpesviral activities of arabinofuranosyl purine and uracil nucleosides
|
Machida, H.
|
|
1997
|
34 |
2 |
p. A76-
1 p.
|
artikel
|
| 100 |
Inhibition of cytomegalovirus by metal chelators: investigations on metabolic pathways
|
Scholz, M
|
|
1997
|
34 |
2 |
p. A83-
1 p.
|
artikel
|
| 101 |
Inhibition of human cytomegalovirus by PMEA
|
|
|
1997
|
34 |
2 |
p. A82-
1 p.
|
artikel
|
| 102 |
Inhibition of pestivirus (BVDV) replication by a cyclic urea derivative
|
Galabov, A.S.
|
|
1997
|
34 |
2 |
p. A90-
1 p.
|
artikel
|
| 103 |
Inhibition of RRE-Rev interaction by RNA-binding polycations
|
|
|
1997
|
34 |
2 |
p. A57-
1 p.
|
artikel
|
| 104 |
Inhibitory effect of hirsutine on influenza virus replication in vitro
|
Konno, K.
|
|
1997
|
34 |
2 |
p. A88-
1 p.
|
artikel
|
| 105 |
Interactions of the HIV fusion inhibitor AR177 (ZINTEVIR) with the HIV type I second receptor
|
Este, J.A.
|
|
1997
|
34 |
2 |
p. A41-
1 p.
|
artikel
|
| 106 |
Interleukin-12 is a novel antiviral therapy
|
Carr, JA
|
|
1997
|
34 |
2 |
p. A46-
1 p.
|
artikel
|
| 107 |
Interspecies scale-up of antiviral nucleoside pharmacokinetics
|
Simmons, P.T.
|
|
1997
|
34 |
2 |
p. A71-
1 p.
|
artikel
|
| 108 |
In vitro activity of the neuraminidase inhibitor GS4071 against influenza viruses
|
|
|
1997
|
34 |
2 |
p. A86-
1 p.
|
artikel
|
| 109 |
In vitro and in vivo effects of RD3-0028 against respiratory syncytial virus
|
Sudo, Kenji
|
|
1997
|
34 |
2 |
p. A88-
1 p.
|
artikel
|
| 110 |
In vitro and in vivo evaluation of the antiherpetic activity of a partially cyclized mu/nu-carrageenan
|
|
|
1997
|
34 |
2 |
p. A78-
1 p.
|
artikel
|
| 111 |
In vitro antiherpetic activity of brivudin: Effect of variable exposure times and evaluation of drug interaction
|
Iafrate, E.M.
|
|
1997
|
34 |
2 |
p. A77-
1 p.
|
artikel
|
| 112 |
In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A
|
|
|
1997
|
34 |
2 |
p. A56-
1 p.
|
artikel
|
| 113 |
In vitro isolation and characterization of a human rhinovirus variant resistant to a 3C protease inhibitor
|
Binford, S.
|
|
1997
|
34 |
2 |
p. A90-
1 p.
|
artikel
|
| 114 |
In vivo anti-cytomegalovirus (CMV) activity and safety of oral lobucavir in HIV infected patients
|
Drew, WL
|
|
1997
|
34 |
2 |
p. A46-
1 p.
|
artikel
|
| 115 |
In vivo influenza virus-inhibitory activity of an orally administered neuraminidase inhibitor
|
|
|
1997
|
34 |
2 |
p. A74-
1 p.
|
artikel
|
| 116 |
Kinetic characterization of HIV-1 reverse transcriptases carrying mutations shown to confer decreased susceptibility to PMEA (adefovir) in vitro
|
|
|
1997
|
34 |
2 |
p. A59-
1 p.
|
artikel
|
| 117 |
Lack of pharmacokinetic interaction between dipyridamole and zalcitabine in rats
|
|
|
1997
|
34 |
2 |
p. A67-
1 p.
|
artikel
|
| 118 |
Lamivudine and penciclovir act synergistically as inhibitors of in vitro hepadnaviral replication penciclovir
|
Shaw, T.
|
|
1997
|
34 |
2 |
p. A64-
1 p.
|
artikel
|
| 119 |
Lethal hepatitis during acute MCMV infection: Analysis and treatment with ganciclovir and HPMPC
|
|
|
1997
|
34 |
2 |
p. A84-
1 p.
|
artikel
|
| 120 |
Line probe assay (LiPA) for HIV-1 RT: Prevalence of drug-selected resistant isolates in HIV-1 infected VA patients
|
|
|
1997
|
34 |
2 |
p. A50-
1 p.
|
artikel
|
| 121 |
Mechanism of inhibition by piperazinyloxoquinoline derivatives as novel HIV-1 transcription inhibitors
|
Okamoto, M.
|
|
1997
|
34 |
2 |
p. A57-
1 p.
|
artikel
|
| 122 |
Metabolism of brivudin (BVDU) in HSV-1 infected cells
|
Ciucci, A.
|
|
1997
|
34 |
2 |
p. A77-
1 p.
|
artikel
|
| 123 |
Methylene blue viral photo-inactivation is associated with formation of RNA-protein crosslinks
|
|
|
1997
|
34 |
2 |
p. A61-
1 p.
|
artikel
|
| 124 |
Molecular properties of HIV-1 resistant to (+)-enantiomers and racemates of oxatiolane cystosine nucleosides and their potential for the treatment of HIV and HBV infections
|
|
|
1997
|
34 |
2 |
p. A42-
1 p.
|
artikel
|
| 125 |
Mycophenolate Mofetil markedly enhances the antiviral activity of acyclovir, ganciclovir and penciclovir against herpes simplex virus (wild type and TK− strains) and human cytomegalovirus
|
Neyts, J.
|
|
1997
|
34 |
2 |
p. A47-
1 p.
|
artikel
|
| 126 |
Nb-containing polyoxometalate HIV-1 protease inhibitors
|
Hill, Craig L.
|
|
1997
|
34 |
2 |
p. A43-
1 p.
|
artikel
|
| 127 |
New 1,1,3-trioxo-2H,4H-thieno[3,4-e]thiadiazine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase
|
Witvrouw, M.
|
|
1997
|
34 |
2 |
p. A56-
1 p.
|
artikel
|
| 128 |
Novel isoforms of HIV-1 nef are expressed by frameshifting and selenium-dependent suppression of UGA termination codons
|
Taylor, E.W.
|
|
1997
|
34 |
2 |
p. A48-
1 p.
|
artikel
|
| 129 |
Oral bioavailability screening of the antirhinoviral vinyl acetylene benzimidazoles
|
Tebbe, M.J.
|
|
1997
|
34 |
2 |
p. A89-
1 p.
|
artikel
|
| 130 |
184 Pentafuside (T-20), a novel inhibitor of HIV-1 fusion: Pharmacokinetics in rodents, monkeys and man
|
|
|
1997
|
34 |
2 |
p. A63-
1 p.
|
artikel
|
| 131 |
Peptide analogs of the human parainfluenza virus fusion protein inhibit viral fusion and virus infection
|
Yao, Qizhi
|
|
1997
|
34 |
2 |
p. A75-
1 p.
|
artikel
|
| 132 |
Peptidomimetic inhibitors of HCMV protease
|
|
|
1997
|
34 |
2 |
p. A45-
1 p.
|
artikel
|
| 133 |
Pharmacokinetic and pharmacodynamic studies of 1-(2-fluoro-5-methyl-β-L-arabinofuranosyl) uracil (L-FMAU) in the woodchuck model of hepatitis B virus (HBV) infection
|
|
|
1997
|
34 |
2 |
p. A52-
1 p.
|
artikel
|
| 134 |
Pharmacokinetic properties and toxicological studies of GPI2A, a gene expression modulator and a potent antiviral agent against HIV-1 virus
|
Anazodo, M.I.
|
|
1997
|
34 |
2 |
p. A63-
1 p.
|
artikel
|
| 135 |
Pharmacokinetics of (-)-2′,3′-dideoxy-5-fluoro-3′-thiacytidine [(-)-FTC] and its metabolites in rhesus monkeys
|
|
|
1997
|
34 |
2 |
p. A68-
1 p.
|
artikel
|
| 136 |
Pharmacokinetics of dioxolane guanine (DXG) following administration of DXG and prodrug, (-)-β-D-2,6-diaminopurine dioxolane (DAPD), to rats
|
|
|
1997
|
34 |
2 |
p. A67-
1 p.
|
artikel
|
| 137 |
Pharmacokinetics of β-L-2′,3′-dideoxy-5-fluorocytidine in rhesus monkeys
|
Martin, L.T.
|
|
1997
|
34 |
2 |
p. A68-
1 p.
|
artikel
|
| 138 |
Pharmacokinetic studies of dipalmitoyl-phosphatidyl-2′,3′-dideoxy-3′-thiacytidine (DPP-3TC) in rodents
|
Manouilov, K.K.
|
|
1997
|
34 |
2 |
p. A67-
1 p.
|
artikel
|
| 139 |
Pharmacological properties of orally active inhibitors of herpes simplex virus (HSV) thymidine kinase
|
Mulqueen, MJ
|
|
1997
|
34 |
2 |
p. A47-
1 p.
|
artikel
|
| 140 |
Phenotypic and genotypic characterization of acyclovir resistant herpes simplex virus
|
Lawrence, W.
|
|
1997
|
34 |
2 |
p. A79-
1 p.
|
artikel
|
| 141 |
Phosphorylation of zidovudine when dosed in an in vitro pharmacodynamic system that simulates in vivo pharmacokinetics
|
|
|
1997
|
34 |
2 |
p. A50-
1 p.
|
artikel
|
| 142 |
Piperazinyloxoquinoline derivatives, potent and selective inhibitors of HIV-1 transcription
|
Baba, M.
|
|
1997
|
34 |
2 |
p. A42-
1 p.
|
artikel
|
| 143 |
Potent and selective inhibitors of herpes simplex virus (HSV) thymidine kinase (TK) reduce reactivation of virus from latency in explanted ganglionic tissue in vitro
|
Mulqueen, MJ
|
|
1997
|
34 |
2 |
p. A78-
1 p.
|
artikel
|
| 144 |
Preliminary efficacy, pharmacokinetics and safety of repeated multiple doses of MKC-442 in HIV-infected volunteers
|
Moxham, CP
|
|
1997
|
34 |
2 |
p. A44-
1 p.
|
artikel
|
| 145 |
Preliminary results on the activity of cidofovir for the treatment of cervical intraepithelial neoplasia (CIN) grade III
|
Snoeck, R.
|
|
1997
|
34 |
2 |
p. A72-
1 p.
|
artikel
|
| 146 |
Proteolytic, active-site mapping of herpesvirus thymidine kinases type 1 and 2 photolabeled with thymidine and ganciclovir photoaffinity analogs
|
|
|
1997
|
34 |
2 |
p. A79-
1 p.
|
artikel
|
| 147 |
Purification and characterization of hepatitis C virus NS3 helicase activity
|
|
|
1997
|
34 |
2 |
p. A92-
1 p.
|
artikel
|
| 148 |
QSAR studies of nucleoside analogs with anti-HIV activity
|
Tsai, C.C.
|
|
1997
|
34 |
2 |
p. A54-
1 p.
|
artikel
|
| 149 |
Rapid method for plaque enumeration in herpes plaque reduction assays
|
|
|
1997
|
34 |
2 |
p. A78-
1 p.
|
artikel
|
| 150 |
Recognition and stabilization of single stranded adenine sequences by thytime base substituted-naphthalene diimide
|
Takenaka, Shigeori
|
|
1997
|
34 |
2 |
p. A91-
1 p.
|
artikel
|
| 151 |
Reduced replication efficiency of 3TC-resistant human hepatitis B virus
|
|
|
1997
|
34 |
2 |
p. A52-
1 p.
|
artikel
|
| 152 |
Rhinovirus 3C protease inhibitors are efficacious against several related picornaviruses
|
Ford, C.
|
|
1997
|
34 |
2 |
p. A90-
1 p.
|
artikel
|
| 153 |
Ribonucleotide reductase inhibitors, didox and trimidox, demonstrate antiretroviral activity alone or in combination with DDI in a murine acquired immunodeficiency (MAIDS) model
|
|
|
1997
|
34 |
2 |
p. A63-
1 p.
|
artikel
|
| 154 |
SAR and molecular modeling studies for the anit-HIV-1 activity optimization of pirryl-aryl-sulphones (PASs). Identification of derivatives with improved potency
|
|
|
1997
|
34 |
2 |
p. A55-
1 p.
|
artikel
|
| 155 |
SCID-hu Thy/Liv mouse model for in vivo human CMV antiviral evaluation
|
|
|
1997
|
34 |
2 |
p. A85-
1 p.
|
artikel
|
| 156 |
Selective activity of 2-hydroxymethylcyclopropylidenemethyl purines against human cytomegalovirus
|
|
|
1997
|
34 |
2 |
p. A83-
1 p.
|
artikel
|
| 157 |
Stavudine (d4T) and didanosine (ddI) combination therapy in HIV-infected subjects: Analysis of antiviral effect and safety ina randomized double-blind study
|
|
|
1997
|
34 |
2 |
p. A50-
1 p.
|
artikel
|
| 158 |
Stereoselective synthesis of 2′ fluorinated nucleosides: A novel method for stereoselective introduction of fluorine into sugar ring precursors
|
|
|
1997
|
34 |
2 |
p. A66-
1 p.
|
artikel
|
| 159 |
Structures of herpes virus proteases: Exciting new targets of antiviral drugs
|
|
|
1997
|
34 |
2 |
p. A45-
1 p.
|
artikel
|
| 160 |
Studies on antiviral effect of extract from Alternanthera philoxeroides Griseb on epidemic hemorrhagic fever virus in vivo
|
|
|
1997
|
34 |
2 |
p. A90-
1 p.
|
artikel
|
| 161 |
Subcutaneous efficacy testing of two antisense oligonucleotides, HYB0184 and HYB0286, in SCID-hu-PBL reconstituted HIV-infected SCID mice
|
Quenelle, D.C.
|
|
1997
|
34 |
2 |
p. A62-
1 p.
|
artikel
|
| 162 |
Substrate specificity of HCV NS3 protease analyzed with modified peptide substrates
|
|
|
1997
|
34 |
2 |
p. A92-
1 p.
|
artikel
|
| 163 |
Synergistic inhibition of in vitro hepadnaviral replication by PMEA and penciclovir or lamivudine
|
|
|
1997
|
34 |
2 |
p. A51-
1 p.
|
artikel
|
| 164 |
Synthesis and anti-HBV activity of 2′-fluoro-β-l-arabinofuranosyl purine nucleosides
|
Ma, T.
|
|
1997
|
34 |
2 |
p. A63-
1 p.
|
artikel
|
| 165 |
Synthesis and antiviral evaluation of benzyl-substituted thiopurine and tiazofurin derivatives
|
Golankiewicz, B.
|
|
1997
|
34 |
2 |
p. A55-
1 p.
|
artikel
|
| 166 |
Synthesis and in vitro antiviral activity of long-chain 5′-O-alkoxycarbonylphosphinyl)-3′-azido-3′-deoxythymidines against drug-sensitive and AZT- or PFA-resistant human immunodeficiency virus type-1 (HIV-1)
|
Rosowsky, A.
|
|
1997
|
34 |
2 |
p. A43-
1 p.
|
artikel
|
| 167 |
Synthesis and isomeric assignment of 2-hydroxymethylcyclopropylidenepurines and -pyrimidines- new antiviral agents
|
|
|
1997
|
34 |
2 |
p. A83-
1 p.
|
artikel
|
| 168 |
Synthesis, anti-HIV and anti-HBV activities of novel oxaselenolane nucleosides
|
Chu, C.K.
|
|
1997
|
34 |
2 |
p. A41-
1 p.
|
artikel
|
| 169 |
Synthesis, enzymology, and anti-HIV studies of analogues of isodideoxyadenosine and its phosphorylated derivatives
|
Nair, V.
|
|
1997
|
34 |
2 |
p. A55-
1 p.
|
artikel
|
| 170 |
Targeting the HIV-1 nucleocapsid protein by azodicarbonamide (ADA), cystamine, and dithiane compounds
|
|
|
1997
|
34 |
2 |
p. A55-
1 p.
|
artikel
|
| 171 |
The anti-herpes simplex virus (HSV) activity of n-docosanol includes inhibition of the viral entry process
|
|
|
1997
|
34 |
2 |
p. A77-
1 p.
|
artikel
|
| 172 |
The antiviral efficacy of topical ZOVIRAX® cream or VECTAVIR® cream in HSV-infected mice
|
Selleseth, D.W.
|
|
1997
|
34 |
2 |
p. A80-
1 p.
|
artikel
|
| 173 |
The combination of tat and NF-κB inhibitor is more effective to suppress the HIV reactivation than either alone
|
|
|
1997
|
34 |
2 |
p. A58-
1 p.
|
artikel
|
| 174 |
The combined presence of the quinoxaline HBY097 and 3TC results in potent suppression of AZT-resistant HIV-1 strains
|
Balzarini, J.
|
|
1997
|
34 |
2 |
p. A58-
1 p.
|
artikel
|
| 175 |
The HIV-1 nef transframe protein has significant sequence and structural similarity to chemokines, as assessed by threading (inverse folding), sequence analysis, and molecular modeling
|
Nadimpalli, R.G.
|
|
1997
|
34 |
2 |
p. A57-
1 p.
|
artikel
|
| 176 |
The inhibitory effect of nonionic surfactants on herpes simplex type 2 replication in vitro
|
|
|
1997
|
34 |
2 |
p. A78-
1 p.
|
artikel
|
| 177 |
The relationship of basal cell layer drug concentration (C*) to the antiviral efficacy: A rigorous evaluation of the C* concept for predicting the entire range of topical efficacy of acyclovir formulations in the treatment of cutaneous HSV-1 infections in hairless mice
|
|
|
1997
|
34 |
2 |
p. A80-
1 p.
|
artikel
|
| 178 |
The relative antiviral efficacy of twice daily cidofovir versus acyclovir and trifluridine in the HSV-1/NZ rabbit keratitis model
|
|
|
1997
|
34 |
2 |
p. A82-
1 p.
|
artikel
|
| 179 |
Three-drug combination of MKC-442, 3TC and AZT in vitro: Potential approach towards effective chemotherapy against HIV-1
|
Piras, G.
|
|
1997
|
34 |
2 |
p. A58-
1 p.
|
artikel
|
| 180 |
Topical and combination use of the anti-HIV phosphorothioate oligonucleotide ISIS 5320
|
|
|
1997
|
34 |
2 |
p. A62-
1 p.
|
artikel
|
| 181 |
Treatment of lethal lassa virus infection in experimental animal model with anti-TNF-α serum
|
Ignatyev, G.M.
|
|
1997
|
34 |
2 |
p. A91-
1 p.
|
artikel
|
| 182 |
Use of human hepatocyte primary cultures to evaluate the cellular pharmacology of anti-hepatitis agents
|
Cretton-Scott, E.
|
|
1997
|
34 |
2 |
p. A66-
1 p.
|
artikel
|
| 183 |
Viral thymidine kinase in essential for the spread of herpes simplex virus (HSV) induced zosteriform lesions in vivo
|
Mulqueen, MJ
|
|
1997
|
34 |
2 |
p. A80-
1 p.
|
artikel
|
| 184 |
Zidovudine induces alterations of apoptosis and resistance to antineoplastic agents in T-cell lymphoma cells
|
Kotchetkov, R
|
|
1997
|
34 |
2 |
p. A60-
1 p.
|
artikel
|
Tijdschrift beschrijving